Anti-Human IL 12/23 (Briakinumab) PE
Product Sizes
50 µg
£594.00
12-8074-50UG
About this Product
- SKU:
- 12-8074
- Additional Names:
- IL-12p40; Interleukin 12; Interleukin 23; IL12; IL23; IL-12; IL-23
- translate.label.attr.clone:
- ABT-874
- Clonality:
- Monoclonal
- Extra Details:
- Expression Host : HEK-293This non-therapeutic biosimilar antibody uses the same variable region sequence as the therapeutic antibody Briakinumab. Briakinumab recognizes both human IL12 and IL23 via IL-12/23p40. This product is for research use only.Briakinumab is a human monoclonal antibody targets the p40 subunit shared by interleukins 12 and 23. IL-12 associates with IL-23alpha to form the heterodimeric cytokine IL-23. IL-23 is associated with various autoimmune inflammatory diseases; and is particularly highly expressed in psoriasis skin lesions. In addition; IL-23 is suspected to play a role in tumorigenesis. Briakinumab binds to and neutralizes human IL-12 and IL-23 (via their shared p40 subunit) and is being investigated for the treatment of rheumatoid arthritis; inflammatory bowel disease; and multiple sclerosis. Anti-Human IL 12/23 (Briakinumab) utilizes the same variable regions from the therapeutic antibody Briakinumab making it ideal for research projects.
- Host:
- Human
- Immunogen:
- This antibody was produced by phage display technology.
- Isotype:
- Human IgG1lambda
- Reactivities:
- Human
- Shipping Conditions:
- Blue Ice
- Storage Conditions:
- This R-phycoerythrin (R-PE) conjugate is stable when stored at 2-8[o]C. Do not freeze.
- Supplier:
- Abeomics
- Type:
- Antibodies:Monoclonal Antibody
- Manufacturer's Data Sheet:download_pdf.php
